Skip to main content

MoneyWorks4Me

Vista Pharmaceuticals informs about disclosure

23 Dec 2022 Evaluate

Vista Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh Gadaley & PACs.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1886.80
Dr. Reddys Labs. 1386.00
Cipla 1410.00
Lupin 2014.00
Zydus Lifesciences 1205.50
View more..